Skip to main content

Lee Bendekgey, Vladimir Vapnik, Ken Welsh

Premium

Lee Bendekgey has joined Nuvelo as senior vice president and general counsel. Bendekgey was previously at Incyte, where he held several executive positions, including executive vice president, general counsel, acting chief financial officer, and acting general manager of the company’s information business. Prior to Incyte, Bendekgey worked for Silicon Graphics, where he held a variety of positions in SGI’s legal group.


Health Discovery Corporation, a systems biology-based biomarker discovery company, has appointed Vladimir Vapnik and Ken Welsh to its scientific advisory board. Vapnik led the machine learning research department at the Institute of Control Sciences in Moscow, where he worked from 1965 to 1990. In the US, he worked at AT&T Bell Laboratories. Welsh is currently a professor of clinical genomics at Royal Brompton Hospital and a scientific advisor to the West London Transplant Center.

Filed under

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.